Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Tafamidis. Show all posts
Showing posts with label Tafamidis. Show all posts
Tuesday, February 19, 2019

US FDA Accepts Regulatory Submissions for Review of Tafamidis to Treat Transthyretin Amyloid Cardiomyopathy

›
In continuation of my update on  Tafamidis Pfizer Inc. (NYSE: PFE) announced today that the US Food and Drug Administration (FDA) ...
Saturday, September 29, 2012

Hint of tafamidis benefit in rare polyneuropathy

›
The results of a randomized trial suggest that tafamidis treatment may slow the progression of early-stage V30M transthyretin familial amy...
Monday, November 28, 2011

European Commission approves Vyndaqel® (tafamidis) for the treatment of Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)

›
We know that, Tafamidis (see structure) or Vyndaqel was discovered in the Jeffery W. Kelly Laboratory at The Scripps Research Institute...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.